id="post-2462" class="twentyseventeen-panel post-2462 page type-page status-publish hentry">

Upcoming Event

This is just a text.


Dear Colleagues,

On behalf of the Organizing Committee of APASL STC Islamabad 2019, it is my great pleasure to welcome all the participants across the country and from abroad to attend the esteemed Conference on Viral Hepatitis from December 5-8, 2019 at Serena Hotel Islamabad, Pakistan. The theme of the meeting is Elimination of Viral Hepatitis by 2030 “From Dream to Reality”.

It is indeed an honor that PSSLD will be holding Third APASL Single Topic Conference this year. PSSLD is working with clear objective to create awareness among health care workers and to sensitize them to the burden of Liver diseases and its implications in the community.

The meeting’s content and activities are tailored to a wide audience of Hepatologists, Gastroenterologists, General practitioners and Postgraduate students. In this meeting we have included several interactive sessions with live audience response. Scientific program has CME credits and offers fantastic updates for consultants, trainees and primary care physicians. Faculty will include international key opinion leaders, mainly from the Asia Pacific region as well as from home.

We urge our colleagues to participate enthusiastically and honor us with their presence. This will be an exciting and educational meet for all.

All the committees are working very hard to make it a memorable event. It would be a great opportunity to meet and network with like-minded colleagues.

It will be winter in Islamabad which is surrounded by Margalla Hills and you will need warm clothing if you intend to move around. Remains of ancient civilization of Ghandara (Taxila) are just nearby (45 minutes’ drive) and if you wish to have a trip to snow covered mountains it is just 40 Km away.

Looking forward to welcome you all in the beautiful city of Islamabad.

Prof. Masood Siddiq
President PSSLD
Chair Organizing Committee



Pre-Conference Workshop

Workshops for PG Trainees & Family Physicians

State of the Art Lectures

Scientific Symposia

Poster Presentation

Free Papers & Presentations


Social Program

Young Investigator Awards


Program Summary

It is indeed an honor that PSSLD will be holding APASL Single Topic Conference this year. We are pleased and honored to inform our esteemed colleagues and participants that a four-day conference on “Elimination of Hepatitis from Dream to Reality” will be held on Dec 5-8, 2019.

Day 1

5th Dec There will be two sessions on research methodology, analysis and how to get the paper published for the post graduates, from 0900 to 1000 hours and then again from 1130 to 1330 hours. This will be followed by a series of case presentations by the trainees from different departments of Gastroenterology across the country which will be discussed threadbare by the attending faculty, both foreign and local.

Day 2

6th Dec The day will be divided into 6 sessions. Sessions I,II,III and V will be dedicated to public health and prevention of hepatitis. Session IV will be the Inaugural Session, and the last session (VI) will be reserved for Free Papers presentations.

Day 3

7th Dec Again the day will be divided into six sessions, for Diagnostic evaluations, Hepatitis Delta, B, C, and chronic liver disease complications.

Day 4

8th Dec The last day there will be only three sessions. First session will be second part of Free Papers, second session will be for hepatocellular carcinoma, and third dedicated to NASH. Lastly there will be simultaneous workshops on NASH, HCC, HCV and Liver disease in Pregnancy.

Event Schedule

Here is our event schedule

Other Details


General Information


The official language of the conference is English, simultaneous translation will not be provided.


In December temperature in Islamabad range from 2C – 24C.

Time Zone

The time zone in Pakistan is Greenwich Mean Time (GMT) + 5 hour.

Banking and Exchange

The Pakistan monetary system is Rupee. Foreign currency may be changed at banks during normal banking hours (09:00-16:00), or hotels, airports and in exchange offices. All major credit cards are acceptable in most hotels, restaurants and shops.

Liabilities & Insurance

The organizer is not able to take any responsibility whatsoever for injury or damage involving persons and property during the meeting. Participants are advised to take out their own personal travel and health insurance for their trip.

Official Letter of Invitation

A personal letter of invitation can be sent to the participants on request.

Visa Requirements

Participants are requested to check with the Pakistani embassy/consulate in their home country or with their travel agency for visa requirements. It is the responsibility of the participant to obtain a visa if required.

Food & Beverages

Business lunches and coffee/tea during breaks (as indicated in the program) are included in the registration fee.

National Airline

Pakistan International Airline is the national airline which operates in all major European, North American and Asian countries. Other airlines operating in Pakistan are: Emirates Airline, Gulf Airlines, Qatar Airlines, Etihad Airlines, British Airlines, Turkish Airlines, Royal Thai Airline Malaysian Airlines, Air China and Thai United.

Hotel Accommodation

Serena Hotel Islamabad: Khayaban-e-Suhrwardy, G-5, Islamabad.
Phone: (+92- 51) 2874000.

Marriott Hotel Islamabad: Agha Khan Rd, F-5/1 Shalimar 5 Islamabad.
Phone: (+92- 51) 2826121


Event Speakers

  • DR. Rino Alvani Gani, SpPD KGEH

    Premier Bintaro Hospital Jl. MH Thamrin No. 1
    Sector 7 Bintaro Jaya
    Tangerang Selatan 15224 - Indonesia
    • Internal Medicine
    • Consultant Gastro Hepatology
    Medical Qualifications / Experience:
    • Medical Staff of the Department of Internal Medicine RSCM / FKUI
    • Premier Bintaro Hospital
    Medical Education:
    • Faculty of Medicine, University of Indonesia, 1987
    • Internal Medicine Specialist Education FKUI, 1996
    • Gastroenterology-Hepatology Consultant FKUI-PAPDI, 2000
    • Medical Virology & Jichi Medical School, Japan, 1998
    Professional Memberships:
    • Member IDI
    • PAPDI Members
    • PPHI Secretary of PEGI
    • PGI Members
  • Fasiha Kanwal, M.D., MSHS

    Houston VA HSR&D Center for Innovations, Quality,
    Effectiveness, and Safety (Office)
    Texas 77021United States
    • Editor-in-Chief
      • Clinical Gastroenterology and Hepatology
    • Professor and Section Chief
      • Medicine
      • Gastroenterology
      • Baylor College of Medicine
      • Houston, Texas
    • Member
      • Dan L Duncan Comprehensive Cancer Center
      • Baylor College of Medicine
      • Houston, Texas, United States
    • M.S.H.S from UCLA School Of Public Health, United States, 2004
    • M.D. from King Edward Medical College, Pakistan, 1995
    • Missouri Medical License
    • National Board of Medical Examiners
    • American Board of Internal Medicine
    • ABIM Gastroenterology Certification
    • ABIM Transplant Hepatology Certification
    Honors & Awards:
    • Editor-in-Chief>
    • Annual meeting distinguished poster
    • Emerging Leaders in Gastroenterology Award
    • Plenary session at the VA National HSR&D Meeting
    • Research Excellence in GI and Liver (REGAL) Award
    Professional Interests:
    • Process and outcomes of care in patients with chronic liver diseases
    • Quality management in liver disease
    • Medical decision-making
    • Patient reported outcomes (health related quality of life)
    • Cost effectiveness analyses
    • Cirrhosis and related complications

    Premier Bintaro Hospital Jl. MH Thamrin No. 1
    Sector 7 Bintaro Jaya
    Tangerang Selatan 15224 - Indonesia
    Personal Profile:

    Lai Wei is a Professor of Hepatology & Medicine, and is the Director of Peking University Hepatology Institute since 2004 and Chief of Department of Hepatology at Peking University People’s Hospital since 2001. His current research interests involve antiviral treatment of hepatitis B and C. Dr. Wei is the President of the Chinese Society of Hepatology. He served to develop the Chinese Guideline for Management of Hepatitis B, and Management, Diagnosis and Prevention of Hepatitis C virus Infection. In addition, Dr Wei is involved in Kidney Disease Improving Global Outcome to develop a Guideline for HCV Infection, Diagnosis, Prevention and Management in Kidney Disease and contributes to APASL for hepatitis C guideline.

  • Tehami, Dr Nadeem A

    BSc, MRCP (UK), MRCP Gastroenterology,
    FEBGH, FRCP (Glasg)
    • Gastroenterology
    • Hepatology (liver) and hepatobiliary (gallbladder and bile ducts) medicine
    Training & Education
    • Undergraduate education/training - Quaid-e-Azam University, Army Medical College, Pakistan (2002)
    • General medical SHO rotation - London South Thames rotation (2004-07)
    • Gastroenterology/hepatology training in various institutions in London, Glasgow and Birmingham between 2007 and 2014 including West Midlands gastroenterology/hepatology rotation
    • Transplant hepatology module - University Hospital of Birmingham (2012-13)
    • HPB endoscopy fellowship - Heart of England NHS Foundation Trust (2013-14)

    Dr Tehami is a consultant gastroenterologist who specialises in hepatology and hepatobiliary medicine. He joined UHS in August 2018. He previously worked as a consultant hepatologist at Shrewsbury and Telford Hospitals NHS Trust for over three years before joining UHS.

    He looks after patients with a wide range of hepatopancreaticobiliary (HPC) problems, but has a specialist interest in HPB endoscopy (ERCP/EUS). His clinical role is divided into inpatient ward work, outpatient clinics and endoscopy lists.

    Dr Tehami's main clinical interests are HPB medicine and endoscopy, endoscopy teaching and training, and improving patient care through education of other health professionals and service development.

    Current roles:
    • MRCP PACES examiner
    • Member of the MRCP part 1/2 question writing group
    • Advance life support instructor (Resus Council UK certified)
    • JAG accredited endoscopy trainer
    • Part of the faculty on PACES and endoscopy training courses overseas
    • Reviewer for Journal of Medical Sciences KMC
    Key Achievements:
    • Dr Tehami cofounded an organisation called PAGHE and initiated the overseas doctors development programme. Under this banner a national conference was arranged for junior doctors which was attended by over 100 delegates. The purpose was to support and guide international medical graduates for the best patient care in the NHS.
    • Dr Tehami has conducted several interview courses overseas for prospective RCP MTI (Medical Training Initiative) programme applicants as an effort to support NHS recruitment.
    • Dr Tehami has an active interest in telemedicine and FOAMed. He has produced several eductional videos for patients and endoscopy nurses.

    Below is a selection of Dr Tehami's most recent publications:

    • Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut. 2015 Jul 1;64(7):1111-9.
    • Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease. QJM: An International Journal of Medicine. 2017 Feb 1;110(2):73-81.
    • Isolated unilateral tongue oedema: the adverse effect of angiotensin converting enzyme inhibitors. Current drug safety. 2012 Nov 1;7(5):382-3.
    • Extrahepatic manifestations of hepatitis C. Frontline gastroenterology. 2013 Nov 4:flgastro-2013.
    • Probiotics' Effects on Perception of Health and Bowel Frequency: A Double Blind Randomized Placebo Controlled Clinical Trial. Gastroenterology. 2017 Apr 1;152(5):S819.
  • Norah Terrault, MD

    Professor Emeritus, Medicine
    513 Parnassus Ave, MSB
    San Francisco, CA 94117
    Education and Training:
    • University of California, San Francisco Post-Doc Fellow/Scholar, Medicine, 1995
    • University of California, San Francisco, Clinical Fellowship, Gastroenterology
    • University of California, San Francisco, Residency
    • University of Alberta, M.D., School of Medicine, 1987
    Research Activities and Funding:
    • Bay Area Hepatitis C Cooperative Research Center
      Role: Co-Investigator (Jun 15, 2010 - May 31, 2015)
    • Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
      Role: Principal Investigator (Sep 30, 2008 - May 31, 2020)
    • Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
      Role: Principal Investigator (Jun 15, 2002 - Jun 30, 2020)
    • Resistance to Antiviral Therapy in Chronic Hepatitis C
      Role: Principal Investigator (Aug 1, 2001 - Apr 30, 2007)
  • Wan-long Chuang

    Vice Superintendent, Kaohsiung Medical University Hospital
    Professor Department of Medicine, Kaohsiung Medical University
    • M.D, School of Medicine, Kaohsiung Medical University
    • MS, Postgraduate Institute, Kaohsiung Medical University, Taiwan
    • PhD, Postgraduate Institute, Kaohsiung Medical University, Taiwan
    • Lecturer, Department of Medicine, Kaohsiung Medical University
    • Associate Professor, Department of Medicine, Kaohsiung Medical University
    • Director, Faculty of Medicine, School of Medicine, Kaohsiung Medical University
    • Chief, Hepatobiliary Division, Department of Internal Medicine
    • Chief, Department of Preventive Medicine
    • Director, Ultrasound Center
    • Specialist of Taiwan Society of Internal Medicine
    • Specialist of the Gastroenterology Society of Taiwan
    • Specialist of Taiwan society of Ultrasound in Medicine
    Professional Specialty:
    • Hepatobiliary and Pancreatic Disease
    • Abdominal Ultrasound Examination
    • Hepatitis Treatment

    Personal Profile:

    Professor Xiaoyuan Xu graduated from thre First Hospital of Lanzhou Medical College in 1988. He is currently a chief of the institue of infectious disease,Peking University.Professor Xu is also a vice chief of the Department of Infectious Disease,Peking Unicersity First Hospital.

    Professor Xu is a standing committee member of the Liver Disease Association of China; a vice chairman of the Liver Disease Association of Beijing,China;a vice leader of the Group of AIDS,Infectious Disease Association of China;a membership of Chinesee Medical Association.Profeesor Xu is editor of National Medical Jornal of China;Chinese Journal of Hepatology;Clinical Internal Medicine Journal of China and World Chinese Journal of Digestology.Professor Xu has published 80 papers about HIV/AIDS/HBV/HCV/SARS.


    President of Chinese Society of Hepatology
    Chinese Medical Association
    Personal Profile:

    Prof. Duan is the Vice President of Beijing Youan Hospital Capital Medical University and President of Chinese Society of Hepatology, Chinese Medical Association. He is also the director of Translational Hepatology Institute of Capital Medical University and Director of Liver Division of Wu Jieping Medical Foundation. He is a Co-chief Editor of Journal of Clinical Hepatology and Chinese Journal of Gastroenterology and Hepatology. He has been the Chairman of Chinese Severe Liver Diseases Meeting (2007-2018).

    Prof. Duan has been awarded Beijing Science and Technology Progress Prize, Chinese Medical Science and Technology Prize, Wu Jieping Prize for Medical Innovation; Science and Technology Progress Prize of Hebei Province and National Prize for Progress in Science and Technology.

  • Jidong Jia

    Professor of Medicine & Director,
    Liver Research Center, Beijing Friendship Hospital,
    Capital Medical University, China
    Personal Profile:

    He received his doctor;s degree from Capital Medical University, Beijing China and finished his postdoctorial training at Klinikum Benjamin Franklin, Free University of Berlin, Germany. His clinical interests include the chronic viral hepatitis, autoimmune and cholestatic liver diseases. His main research work includes the pathogenesis and treatment of l liver fibrosis.

    He is the President-Elect of IAS, Past President of APASL (2009-2010) and Immediate Past President of the Chinese Society of Hepatology. He currently serves China Foundation of Viral Hepatitis Prevention and Control as vice president, and CEVHAP as Executive Council Member. He also serves as associate editor for Journal of Gastroenterology & Hepatology and Hepatology International.

  • Professor Dr. A. Kadir Dökmeci

    Ilgaz / Çankiri Turkey
    • 1954-1965 Primary and High School Ankara
    • 1965-1971 Ankara University Faculty of Medicine
    • 1971-1976 Assistant, Department of Internal Medicine, AÜTF
    • 1976-1978 Assistant, Department of Gastroenterology, AÜTF
    • 1978-1979 Chief Assistant, Department of Gastroenterology
    • 1979-1979 Japanese Course, Osaka, Japan, (6 Months)
    • 1979-1981 Study, training and research, 1st Internal Medicine Clinic of Chiba University School of Medicine
    • 1981-1981 Visiting Researcher, Goethe University Medical School Gastroenterology Clinic (1 Month)
    • 1981-1981 Observer Specialist, Northwestern University School of Medicine.Chicago, (20 Days) USA
    • 1981-1982 Gastroenterology Specialist, AÜTF
    • 1982-1988 Associate Professor, Department of Gastroenterology, AÜTF
    • 1988 Appointment as Professor, Department of Gastroenterology, AÜTF
    • 1988-1989 Visiting Professor .Chiba University. Chiba, Japan
    • 1989 ERCP Course. Middlesex Hospital. London, England
    • 1989-1994 Professor, Department of Gastroenterology, AÜTF
    • 1994-1997 Presidency of Internal Medicine, AÜTF
    • 1997-2000 Department of Gastroenterology, AÜTF
    • 2002-2003 Visiting Professor, Department of Gastroenterology, University of California, Irvine, Los Angeles, USA
    • 2003 Professor, Gastroenterology, AÜTF
    • INOHANA Award Contribution to Turkish-Japanese cooperation in the field of Gastroenterology
    • Ankara University Medical School, Turkey
    • Chiba University School of Medicine, Japan
    • Gethoe University, Frankfurt, Germany
    • University of Calfornia, Irvine, USA
    • Medical Diploma
    • Internal diseases
    • Gastroenterology
    • 1973 Turkish Gastroenterology Association
    • 1994-1998 Member of the Board
    • 1984 International Association for the Study of the Liver (IASL)
    • 1985 Turkish Ultrasonography Association
    • 1988 Japanese Society of Gastroenterology
    • 1990 Gastrointestinal Endoscopy Association
    • 1990-1998 Member of the Board
    • 1991 Turkish-Japanese University Association
    • 1991-1995 Member of the Board
    • 1991-1994 Member of the Regulatory Commission for Gastroenterology Drugs of the Ministry of Health
    • 1992 Turkey's Liver Research Association
    • 1994-2000 Presidency of Gastroenterology Drugs Regulatory Commission of Ministry of Health
    • 1996 Turkish Society of Surgical Hepato-Pancreato-Bilier Diseases
    • 1996 Turkish-Japanese Foundation
    • 2002 Hepato-Bilio-Pancreatology Association (HEBIPA) President
    • 2003 International Society of Gastroenterology and Surgery
  • Prof. Gregory Dore

    Professor and Program Head
    Viral Hepatitis Clinical Research Program, Sydney
    Personal Profile:

    Professor Dore is Head, Viral Hepatitis Clinical Research Program, Kirby Institute, UNSW Sydney, and Infectious Diseases Physician, St Vincent’s Hospital, Sydney, Australia. He has been involved in viral hepatitis and HIV epidemiological and clinical research, clinical care and public health policy for 20 years. He has developed extensive national and international collaborations, and is internationally recognized in the areas of HCV natural history and epidemiology, therapeutic strategies for acute and chronic HCV infection, particularly among people who inject drugs, and HCV elimination strategies.

    Professor Dore established the St Vincent’s Hospital viral hepatitis service in 1999, and has led its development into one of the leading national and international hepatitis C treatment services, with a particular focus on marginalised populations including people who inject drugs and homeless persons.

    • 2001 PhD, University of New South Wales
    • 1997 MPH, University of Sydney
    • 1995 FRACP, Royal Australasian College of Physicians
    • 1987 BSc, University of New South Wales
    • 1987 MBBS, University of New South Wales

    Major Category 1 Grants

    • NHMRC: Practitioner Fellowships (2012-2016: $523K; renewed for 2017-2021: $569K).
    • NHMRC Program Grant as CI (2014-2018: Hepatitis C infection: epidemiology, pathogenesis, and treatment; $5,428K, $1,307K to Dore)
    • NHMRC Partnership Grants as CI (2014-2019: Surveillance and Treatment of Prisoners with hepatitis C (SToP-C), $1,495K; 2016-2020: Enhancing hepatitis C virus among injecting drug users in the opiate pharmacotherapy setting, $1,490K).
    • NIH R01 Grants as CI (2015-2020: A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (REACT study), $US 3,700K; 2011-2016: International Collaborative of prospective studies of HIV and Hepatitis in IDU, $2,289K).
    • 2007, 2012, 2017 NHMRC Practitioner Fellowship
    • 2007 Frank Fenner ASID Award for Advanced Research in Infectious Diseases
    • 2016 Fellow of Australian Academy of Health and Medical Science
  • Prof. Jinlin Hou

    Director and Professor of
    The Hepatology Unit
    Department of Infectious Diseases
    Personal Profile:

    Professor Jinlin Hou is the Director and Professor of the Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Professor Hou is the president of APASL 2017 and the president of Chinese Medical Association of Infectious Diseases(2013-2016. Professor Hou joined the University Department of Medicine of Nanfang Hospital in July 1984. Between 1993 and 1994,he received training in the Department of Medicine at St. Mary’s Hospital Medical School in London, UK. Between 2000 and 2001, Professor Hou was a visiting Fellow at the Institute of Hepatology, London, UK. He has been invited to deliver talks at both national and international liver conferences owing to his expertise in viral hepatitis and other liver diseases. His current research interests include the clinical management of liver and Infectious Diseases and the molecular virology and immunology of hepatitis virus infection. He has published more than 500 articles in both national and international journals, including GUT, Hepatology, Journal of Immunology,Journal of Hepatology, Science,LANCET Infect Dis, NEJM et al.

  • NECATİ Örmeci

    Departments of Medical Sciences
    Personal Profile:

    I was born in 1952 in the Senirkent district of Isparta. I finished primary and secondary school here. In 1976, I graduated from Ankara University Faculty of Medicine. About a week after my graduation, I became an assistant in the Department of Internal Medicine at the same faculty. Between 1983-85, I specialized in Gastroenterology and in 1985 I became an assistant professor in Ankara University Faculty of Medicine, Department of Gastroenterology. I went to Japan in 1985 and studied at Tokyo Women's Medical Collage on diagnostic endoscopy, endoscopic ultrasonography and endoscopic interventions. I returned from Japan at the end of 1986. I became an associate professor in 1988. In 1990, with a scholarship from TUBITAK, I also worked in Tokyo National Cancer Center for 4 months on endoscopy, cytology and histepatology of early gastric cancer. I became a professor in 1994. In 1999, I worked for a month at the Cleveland Clinic in Miami to improve my knowledge and experience. I am still working in Ankara University Faculty of Medicine Department of Gastroenterology. In September 2006, I was elected as the Head of the Internal Medicine Department of our faculty.

  • Bilal Hameed, MD

    Associate Professor, Hepatologist
    Personal Profile:

    Dr. Bilal Hameed is specialist who cares for patients with liver disease. His expertise includes providing care before and after liver transplantation.

    Hameed earned his medical degree at Dow University of Health Sciences in Pakistan and completed an internal medicine residency at the University of Minnesota. He completed a fellowship in gastroenterology at the University of Minnesota and a fellowship in transplant hepatology at UCSF.

    In addition to authoring numerous peer-reviewed articles, Hameed has received many awards and honors in his field. He is a member of the American Association for the Study of Liver Diseases, American Gastroenterological Association and American Society of Transplantation.

    Board Certification:
    • Transplant Hepatology, Amer Bd of Internal Medicine/Transplant Hepatology
    • Gastroenterology, American Board of Internal Med/Gastroenterology
    • Dow School of Medicine 2000
    • University of Minnesota, Internal Medicine 2006
    • University of Minnesota, Gastroenterology 2009
    • UCSF Medical Center, Transplant Hepatology 2010
    Selected Research and Publications:
    1. Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver Int. 2019 May 13.
    2. Leventhal TM, Gottfried M, Olson JC, Subramanian RM, Hameed B, Lee WM. Acetaminophen is Undetectable in Plasma From More Than Half of Patients Believed to Have Acute Liver Failure Due to Overdose. Clin Gastroenterol Hepatol. 2019 Feb 05.
    3. Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. Hepatology. 2019 Jan 19.
  • Professor Salimur Rahman

    Professor of Hepatology Bangabandhu Sheikh Mujib
    Medical University Shahbagh,
    Dhaka-1000, Bangladesh.
    Personal Profile:

    Professor Salimur Rahman is a veteran Hepatologist of Bangladesh and at present working as professor of hepatology Bangabandhu Sheikh Mujib Medical University which is the only medical university of this country. He is one of the founders of the discipline in this country. He is a co-editor of 1) ‘Liver: A Complete Book on HepatoPancreato-Biliary Diseases’ and 2) ‘Comprehensive Text Book of Hepatitis B’ published by Elsevier and Jaypee respectively. Professor Rahman has over 100 publications in international and regional journals. He is Editor-in-Chief of Euroasian Journal of Hepato-Gastroenterolgy, the official publication of Euroasian Gastroenterological Association and Viral Hepatitis Foundation Bangladesh. He is the current President of Association for the Study of the Liver, Dhaka, Bangladesh – the national association of Hepatologists of the country and the Senior VicePresident of Association of Physicians of Bangladesh – the premier platform of specialist physicians of Bangladesh. He is also the founder Chairman of Viral Hepatitis Foundation Bangladesh. He served as member national committee for Hepatitis B virus in Bangladesh and presently serving as executive committee member of Asian Pacific Association for the study of the Liver (APASL). He is the current president of South Asian Association for the Study of Liver (SAASL). Professor Salimur Rahman is a leading interventionist of Bangladesh and has pioneered the transformation of Hepatology from a theoretical to an interventional super-specialty in this country. He is a senior faculty member of the Department of Hepatology, Bangabandhu Sheikh Mujib Medical University. He is a Fellow of Bangladesh College of Physicians and Surgeons, Royal College of Physicians of Edinburgh and Royal College of Physicians of Dublin.


Organizing Committee


Prof. Wasim Jafri

President & Chair Organizing Committee

Prof. Masood Siddiq

Steering Committee
  • Prof. Wasim Jafri
  • Prof. Saeed Hamid
  • Prof. Masood Siddiq
  • Prof. Zaigham Abbas
Organizing Committee
  • Prof. A.A Durrani
  • Prof. Muzzafar Latif Gill
  • Prof. Javaid Aslam Butt
  • Prof. Tassawar Hussain
  • Prof. Shoaib Shafi
  • Prof. Faisal Saud Dar
  • Prof. Ghias-un-Nabi Tayyab
  • Dr. Mashood Ali Khan
  • Dr. Adil Naseer
  • Dr. Arshad Abbasi
  • Dr. Altaf Baqir Naqvi
  • Prof. Wazir Sheikh
  • Prof. Bashir Sheikh
Scientific Committee
  • Prof. Amjad Salamat (Chair)
  • Dr. Muhammad Salih (Co-Chair)
  • Dr. Najam ul Hassan Shah
  • Prof. Farrukh Saeed
  • Dr. Muhammad Naseet
  • Prof. Zafar Ali
  • Dr. Lubna Kamani

Form Submissions


Abstract should be developed according to following format and should not be of more than 250 words. Last date for Abstract Submission is October 31, 2019

Click here for Offline Submission

Click here for Offline Submission

Mode of Payment: Cheque made payable to Pakisan Society for the study of liver Deseases
Bank/Branch: Askari Bank, DHA Phase 1 Rawalpindi. Account Number: 1060 10000 5489 000

Message Us

Font Resize
Time Activity
0900-0930 Registration
DAY 1: Thursday, 05 Dec 2019
Session-I: Post Graduates Day: Research Workshop
Venue: Marriot Islamabad
Time: 0930-1110 hrs.
Director: Yasir Waheed
Time Topic Speaker
0930-0940 Welcome Message Masood Siddiq
0940-1000 Study Designs in Medical Research Dilshad Ahmed Khan
1000-1020 Ethics & Integrity in Research Saeed Sadiq Hamid
1020-1040 Data Management & Analysis Aamir Ijaz
1040-1100 How to do a good Meta-Analysis Fasiha Kanwal
1100-1110 Q & A and Discussion
1110-1140 Tea Break
DAY 1: Thursday, 05 Dec 2019
Session-II: Post Graduates Day: Research Workshop (Contn’d)
Venue: Marriot Islamabad
Time: 1140-1310 hrs.
Director: Yasir Waheed
Time Topic Speaker
1140-1200 How to Write a Good Research Paper Amna Subhan Butt
1200-1220 Translational Research “Its Impact on Health Outcomes” Syed Mohammad Wasim Jafri
1220-1240 How to Publish in High Quality Scientific Journals Fasiha Kanwal
1240-1300 How to Improve Research Paper before Submission into Journal and Pre-submission Checklist Yasir Waheed
1300-1310 Q & A and Discussion
1310-1500 Lunch / Registration Serena and Back
DAY 1: Thursday, 05 Dec 2019
Session-III: Post Graduates Day - Case based PG workshop
Venue: Marriot Islamabad
Time: 1500–1830 hrs.
Director: Mohammed Salih
Asst-Director: Dr. Yasir Abbas
Time Session Speaker Supervisor Moderator Topic Chair persons
1450-1500 Introduction by Workshop Director
1500-1520 Case-1 Hammad Azam Jehanzeb Afridi Masood Siddiq Refractory Ascites Kadir Dockmeci
Necati Ormeci
Shahab Abid
1520-1540 Case-2 Waqar Ali Shah Adil Naseer Khan Acute on Chronic Recurrent Encephalopathy
1540-1600 Case-3 Kumail Hassan Kazmi Farrukh Saeed Variceal Bleed Management after Endoscopy Failure
1600-1610 Wrap up by chairs
1610-1630 Case-4 Ghulam Fareed Amna Subhan Butt Altaf Alam Sepsis Induced ACLF Seyed Moayed
Rino A Gani
Nadeem Tehami
1630-1650 Case-5 Ajeet Kumar Zahid Azam HBV Induced ALF
1650-1710 Case-6 Dr. Hyder Wajid Abbasi Mashhood Ali Khan DILI (Anti TB Drugs induced)
1710-1720 Wrap up by chairs
1720-1740 Case-7 Adnan Shabbir Akif Dilshad Muhammad Salih Pre-Transplant Assessment and Transplant in CLD because of NASH Norah Terrault
Bilal Hameed
Najam Ul Hasssan Shah
1740-1800 Case-8 Ali Qadeer Zaigham Abbas PBC case scenario
1800-1820 Case-9 Umair Shafqat Shahid Rasool Autoimmune Hepatitis Resistant to Steroids
1820-1830 Wrap up by chairs
1900-1930 Dinner
1930- Transfer and Check in Serena Hotel Islamabad

This session will be case based presentations by PG GI trainees; it will be 10 min presentation and 10 min discussion

DAY 2: Friday, 06 Dec 2019
Session-I: Public Health Seminar
Venue: Serena Islamabad
Time: 0900-1040 hrs.
Moderator: Arsalan Shahzad
Chairs: Zhongping Duan, Wasim Jafri
Time Topic Speakers
0900-0910 Opening and WELCOME Masood Siddiq
0910-0925 Who is Spreading Hepatitis What are we doing about it? Faisal Wasim Ismail
0925-0940 Role of Transfusion Services in Prevention of Hepatitis Nuzhat Salamat
0940-0955 Decentralizing the HCV Health Care Delivery to Primary Care - is it time? Ghias un Nabi Tayyab
0955-1010 Good and Simplified Service Delivery for HCV Care in a Resource Limited Country Imam Waked
1010-1025 Key challenges for HCV Elimination in Public Health Domain Fasiha Kanwal
1025-1040 Effective Policy for HCV Elimination, Ways and Means Ministry of Health (Masood)
1040-1100 Tea break
DAY 2: Friday, 06 Dec 2019
Session-II: Public Health Seminar
Venue: Serena Islamabad
Time: 1055-1300 hrs.
Chairs: Javaid Aslam Butt, Tassawar Hussain, Col Saad Rao
Time Topic Speakers
1100-1115 Is Prevention on Back Burner in the Era of DAAs? Saeed Sadiq Hamid
1115-1130 Global Progress in Elimination of Hepatitis What do the Numbers Tell us? Hassan Mahmood
1130-1145 Role of Innovation in Technology and delivery approach for Elimination of Viral Hepatitis Norah Terrault
1145-1200 HCV Elimination, Lessons from Egypt Imam Wakeed
1200-1215 Q&A – Discussion
1215-1230 HCV Elimination in Pakistan Huma Qureshi
1230-1245 Changing the Behavior Public and Personal does it Matter? Mowadat Hussain Rana
1245-1300 Media Partnership for HCV and HBV Elimination Wasif Nagi – Geo Group
1300-1400 Lunch & Prayer
DAY 2: Friday, 06 Dec 2019
Session-III: Public Health Seminar
Venue: Serena Islamabad
Time: 1400-1530 hrs.
Chairs: Ejaz Mohammad Khan, Qazi Masroor Ali, Javed Afridi
Time Topic Speakers
1400-1415 Role of Professional Bodies In HCV Elimination, Is Some Body Listening? Wasim Jafri
1415-1430 Drug Regulation Policies and Hepatitis Elimination DRAP C/O Huma
1430-1445 Politics of Advocacy for Hepatitis Elimination, Who should own it?
1445-1505 Q&A - Discussion
1505-1530 Patients Perspective Khalid Mahmood Gondal + Ali Noor
DAY 2: Friday, 06 Dec 2019
Session-IV: Inaugural Session
Venue: Serena Islamabad
Time: 1600-1700 hrs.
1530-1545 Guests to be seated
1600-1605 Tilawat from The Holy Quran
1605-1610 National Anthem
1610-1615 Welcome Address by The President PSSLD & Chair Organizing Committee Masood Siddiq
1615-1620 Address by the Chair Scientific Committee Amjad Salamat
1620-1625 Address by the Representative of Chinese Delegates
1625-1630 Address by the Patron PSSLD Waseem Jafri
1630-1635 Presentation of Memento to the Chief Guest
1635-1700 Address by the Chief Guest
1700-1715 Tea Break
DAY 2: Friday, 06 Dec 2019
Session-V: Regional Perspectives
Venue: Serena Islamabad
Time: 1715-1820 hrs.
Chairs: Noor Mohammad, Bakht Biland, Kamran Hassan
1715-1725 Elimination of Viral Hepatitis - Progress in Azerbaijan Gulnara Aghayera
1725-1740 Elimination of Viral Hepatitis - Progress in Bangladesh Salim Ur Rehman
1740-1750 Elimination of Viral Hepatitis - Progress in Indonesia Rino A Gani
1750-1800 Elimination of Viral Hepatitis - Progress in Iran Alavian
1800-1810 Elimination of Viral Hepatitis - Progress in Turkey Kadir / Necati
1810-1820 Elimination of Viral Hepatitis - Progress in China
1820-1830 Change Over
DAY 2: Friday, 06 Dec 2019
Session-VI: Free Papers
Venue: Serena Islamabad
Time: 1830-2030 hrs.
Chairs: Asim Anwar, Junaid Saleem, Zahid Azam
1820-2000 Free papers
2030 Dinner
DAY 3: Saturday, 07 Dec 2019
Session-I: HBV Symposium I
Venue: Serena Islamabad
Time: 0900-0945 hrs.
Chairs: Shoaib Shafi, H.M. Ashraf, Shuang Liu
Time Topic Speakers
0900-0915 HBV Viral Quasi-species and its Clinical Significance Li Chen
0915-0930 Effect of Hirudin on Farnessol X Receptor Pathway during Acute Intrahepatic Cholestasis Fan Yang
0930-0945 Nucleoside Analogues Combined with TCM Anti-Fibrosis Ameliorate Prognosis of Chronic Hepatitis B Yuemin Nan
0945-0950 Q&A
DAY 3: Saturday, 07 Dec 2019
Session-II: HDV Symposium
Venue: Serena Islamabad
Time: 0955-1115 hrs.
Chairs: Muzaffar Latif Gill, Saeed Sadiq Hamid
Time Topic Speakers
0955-1020 State of the Art lecture:
HDV Replication and Detection In Hepatocytes
Mario Rizetto
0955-1010 Distribution of HDV Genotypes and its effects on disease course and response to treatment Gulnara Aghayera
1010-1025 The Oncogenic role of HDV infection Zaigham Abbas
1025-1040 Epidemiology of HDV Infection in Middle East Countries and Iranian experience with therapy and control of HDV infection. Alavian MS
1040-1045 HDV Management in 2019 and beyond? Mario Rizetto
1045-1115 Q&A
1115-1130 Tea Break
DAY 3: Saturday, 07 Dec 2019
Session-III: HBV Symposium II
Venue: Serena Islamabad
Time: 1130-1250 hrs.
Moderator: Faisal Wasim Ismail
Chair: Khalid Mahmood, Altaf Baqir Naqvi
1130-1145 Mother to child transmission, HBV Management in Pregnancy Altaf Alam
1145-1200 Management of HBV Cirrhotics with and without Co-infection Sadik Memon
1200-1215 Chronic Hepatitis-B Treatment Options and Goals Wasim Jafri
1215-1220 Q&A
1220-1255 State of the Art lecture:
HBV from Functional to Complete Cure, Do East & West Differ in their Approach?
Norah Terrault
1255-1400 Lunch & Prayer
DAY 3: Saturday, 07 Dec 2019
Session-IV: HCV
Venue: Serena Islamabad
Time: 1410-1600 hrs.
Chair: Israr-ul-Haq Toor, Farrukh Saeed, Shamail Zafar
Time Topic Speaker
1400-1415 Point of Care Testing in HCV Saeed Sadiq Hamid
1415-1430 HCV Treatment Naïve in 2019 Ghias un Nabi Tayyab
1440-1455 Treatment Failure in Era of DAAs Zaigham Abbas
1455-1500 Detection of Residual HCV-RNA in Patients who have Achieved SVR is Associated with Persistent Histological Abnormality Jinmin Zhao
1500-1515 Management of HCV in Decompensated CLD Bilal Hameed
1515-1530 Post Liver Transplant HCV Treatment Norah Terrault
1530-1535 Q&A
1535-1600 State of the Art lecture:
Management Landscape in Asia: Clinical Reality
Wasim Jafri
1600-1610 Break / Change Over
DAY 3: Saturday, 07 Dec 2019
Session-V: Care of Cirrhotics Clinical Hepatology
Venue: Serena Islamabad
Time: 1610-1710 hrs.
Chair: Arif Nadeem, Bakht Biland, Noor Muhammad
Time Topic Speaker
1610-1625 Diagnosis of Cirrhosis Staging and Clinical Significance Muzaffar Latif Gill
1625-1640 Management of Ascites in Cirrhotics Amjad Salamat
1640-1655 Role of Albumin in Cirrhotics Beyond Plasma Expansion Nadeem Tehami
1655-1710 Variceal Bleed, New Developments Building on Old Knowledge Necati Ormeci
1710-1730 Tea Break
DAY 3: Saturday, 07 Dec 2019
Session-VI: Cirrhosis - Potpouri
Venue: Serena Islamabad
Time: 1730-1900 hrs.
Chair: Shahab Abid, Sadiq Achakzai, Waseem Sarwar Malghani
Time Topic Speaker
1730-1745 Diagnosis and Management of NAFLD Jiangao Fan
1745-1800 Hepatic Encephalopathy - Practical Approach. Israr Toor
1800-1815 Optimal and Effective use of Medications in Cirrhotics Bilal Hameed
1800-1830 Multi detector CT for Hepatic Fibrosis, parameters and accuracy Aman Nawaz Khan
1830-1845 Pain Management in Cirrhotics Saleem ur Rehman
1845-1900 Algorithms in Care of Cirrhosis vs Traditional Approach or Combination - Pros and Cons Fasiha Kanwal
1900-1910 Q&A
2000-2045 Dinner
2100 Cultural Evening
DAY 4: Sunday, 08 Dec 2019
Session-I: Free papers
Venue: Serena Islamabad
Time: 0800-0915 hrs.
Chair: Asim Anwar, Junaid Saleem, Zahid Azam
0800-0915 Free Paper Session
DAY 4: Sunday, 08 Dec 2019
Session-II: Hepatocellular Carcinoma
Venue: Serena Islamabad
Time: 0930-1100 hrs.
Chair: Shahid Rasool, Ehsan Kiyani, Shahzad Riaz
Time Topic Speaker
0930-0945 What should Pakistan do to have an Effective Surveillance for HCC Zahid Azam
0945-1000 HCC management who should do it and how? Rino A Gani
1000-1015 HCC treatment BCLS or modified model Najam Ul Hassan Shah
1015-1030 Loco regional Curative and Non-Curative Therapies for HCC Kadir Dockmeci
1030-1045 Out of criterion TACE for HCC Atif Rana
1045-1100 Out of Criterion LDLT for HCC Faisal Dar
1100-1115 Tea break
DAY 4: Sunday, 08 Dec 2019
Session-III: CLD and NASH
Venue: Serena Islamabad
Time: 1115-1215 hrs.
Chair: Habib Jadoon, Adil Naseer Khan, Arshad Abbasi
Time Topic Speaker
1115-1130 Imaging in Chronic Liver Disease Ehsan Kiyani
1130-1145 Noninvasive Serological Markers of Fibrosis in Chronic Hepatitis Rino A Gani
1145-1200 Pathophysiology of NASH Mohammad Salih
1200-1215 Future Therapies for NASH Bilal Hameed
DAY 4: Sunday, 08 Dec 2019
Session-IV: Case Based Workshops Venue: Serena Islamabad - Different Halls
Time: 1235-1405 hrs.
Time Topic Target Audience Facilitators
1235-1405 Specific Liver Diseases of Pregnancy General Lubna Kamani, Amna Subhan Butt, Qazi Masroor Ali
1235-1405 NASH General Saeed Sadiq Hamid, Bilal Hameed, Mohammad Naseer
1235-1405 HCV Diagnosis and Treatment GPs/PGs Wasim Jafri, Faisal Wasim Ismail, Naeem Ullah
1235-1405 MDT for HCC PGs Najam ul Hassan Shah, Norah Terrault, Muhammad Salih
Concluding Ceremony 1410-1430 hrs.
Prize + Certificate Distribution
Lunch 1430-1500 hrs.